Celebrities are increasingly open about using weight-loss drugs like Ozempic and Mounjaro, originally for diabetes, to ...

The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...

Netizens have found that Karan Johar looks aged and has been shrinking a lot in his latest snaps. They have blamed it on Ozempic and anti obesity drugs.

The company’s new range promises to elevate nutritional support for consumers on weight management medications ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

The demand for obesity drugs in India surges as Eli Lilly and Novo Nordisk vie for market share. Meanwhile, President Trump ...

Novo Nordisk seeks EMA approval for 7.2 mg Wegovy dose after trials show 21% weight loss in people with obesity and type 2 diabetes.

Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...

India is stepping into the billion-dollar weight-loss drug war! With Wegovy and Mounjaro already here, Biocon is quietly ...

Lilly to launch Mounjaro pen in India to compete with Novo's weight-loss drug Wegovy Lilly started selling Mounjaro in India in late March for diabetes and obesity, and it was so far available ...

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, intensifying the race for India's booming obesity drug market.